Anika Therapeutics, Inc. financial data

Symbol
ANIK on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
32 Wiggins Avenue, Bedford, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
ANIKA RESEARCH INC (to 11/27/1996)
Latest financial report
Q1 2024 - May 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 568 % -3.99%
Quick Ratio 164 % +20%
Return On Equity -31.8 % -305%
Return On Assets -25.8 % -302%
Operating Margin -47.4 % -163%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.8M shares +1.34%
Common Stock, Shares, Outstanding 14.8M shares +0.54%
Entity Public Float 370M USD +15.1%
Common Stock, Value, Issued 148K USD +0.68%
Weighted Average Number of Shares Outstanding, Basic 14.7M shares +0.31%
Weighted Average Number of Shares Outstanding, Diluted 14.7M shares +0.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD +7.49%
Research and Development Expense 32.5M USD +6.67%
Costs and Expenses 185M USD +50.4%
Operating Income (Loss) -80.1M USD -182%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -77.8M USD -188%
Income Tax Expense (Benefit) -953K USD +80%
Net Income (Loss) Attributable to Parent -76.8M USD -245%
Earnings Per Share, Basic -5.24 USD/shares -242%
Earnings Per Share, Diluted -5.24 USD/shares -242%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 68.6M USD -13.9%
Marketable Securities, Current 32.1M USD +4.73%
Accounts Receivable, after Allowance for Credit Loss, Current 32.1M USD +4.73%
Inventory, Net 49.4M USD +19.6%
Assets, Current 159M USD -0.85%
Deferred Income Tax Assets, Net 1.27M USD -16.2%
Property, Plant and Equipment, Net 46.1M USD -5.63%
Operating Lease, Right-of-Use Asset 28.2M USD -6.61%
Intangible Assets, Net (Excluding Goodwill) 4.3M USD -94.1%
Goodwill 7.4M USD -0.79%
Other Assets, Noncurrent 17.6M USD -3.09%
Assets 264M USD -22.2%
Accounts Payable, Current 10M USD +12%
Employee-related Liabilities, Current 8.6M USD +11.4%
Liabilities, Current 28.5M USD -0.81%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 26.3M USD -6.85%
Other Liabilities, Noncurrent 404K USD +1.25%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6.32M USD -2.33%
Retained Earnings (Accumulated Deficit) 124M USD -38.3%
Stockholders' Equity Attributable to Parent 209M USD -24.9%
Liabilities and Equity 264M USD -22.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -126K USD +96.5%
Net Cash Provided by (Used in) Financing Activities -2.27M USD -40.9%
Net Cash Provided by (Used in) Investing Activities -1.81M USD -30.2%
Common Stock, Shares Authorized 90M shares 0%
Common Stock, Shares, Issued 15M shares +1.82%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.24M USD +35.7%
Deferred Tax Assets, Valuation Allowance 18.1M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 35.3M USD +52.3%
Depreciation 6.4M USD -4.48%
Payments to Acquire Property, Plant, and Equipment 1.81M USD +30.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -77M USD -240%
Property, Plant and Equipment, Gross 93.9M USD -0.63%
Operating Lease, Liability, Current 2.13M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14M USD +2.85%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.13M USD -1.23%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) 193K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.95M USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.84M USD -7.47%
Deferred Tax Assets, Operating Loss Carryforwards 1.16M USD -25.1%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) -5.05M USD -55.6%
Current Income Tax Expense (Benefit) 3.77M USD +172%
Preferred Stock, Shares Authorized 1.25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.64M USD -4.24%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 309K USD +8.42%
Current Federal Tax Expense (Benefit) 3.15M USD +214%
Amortization of Intangible Assets 300K USD -84.2%
Deferred Tax Assets, Net of Valuation Allowance 17.2M USD -25.7%
Share-based Payment Arrangement, Expense 15.1M USD -2.4%
Deferred State and Local Income Tax Expense (Benefit) -1.42M USD -12.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%